Tags : Pre-menopausal Women

AbbVie and Neurocrine’s Oriahnn Receive the US FDA’s Approval as

Shots: The approval follows P-III ELARIS UF-I and ELARIS UF-II studies assessing Oriahnn (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules) vs PBO for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women for up to 24mos. The study met its 1EPs of clinically meaningful reduction in bleeding (defined as the […]Read More